Overview

• Insolvency administrator Malte Köster confirmed that the takeover by a consortium led by Abacon and Salvia closed in early July under insolvency protection.
• Approximately 80% of jobs at the Itzehoe headquarters are retained, preserving ongoing research, development and battery production for existing customers.
• The Tübingen plant has no prospect of reopening and will undergo an orderly wind-down in the coming weeks.
• CustomCells plans to exit its loss-making aerospace segment and refocus on defense-sector battery applications under the new ownership.
• Leadership will be restructured as innovation chief Jan Diekmann and Benno Leuthner join the executive board and former CEO Dirk Abendroth transitions to an advisory role.